Correction to: Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)

After publication of our article [1] we were notified that the data presented in the upper row of Fig. 7 was inadvertently the least square mean change from baseline (standard error) at Month 6 rather than the overall average of Month 3 and Month 6. The figure legend and discussion of the data in th...

Full description

Saved in:
Bibliographic Details
Published inJournal of headache and pain Vol. 20; no. 1; pp. 118 - 2
Main Authors Silberstein, Stephen D., Stauffer, Virginia L., Day, Katie A., Lipsius, Sarah, Wilson, Maria-Carmen
Format Journal Article
LanguageEnglish
Published Milan Springer Milan 27.12.2019
Springer Nature B.V
BMC
Subjects
Correction
Internal Medicine
Medicine
Medicine & Public Health
Neurology
Pain Medicine
Online AccessGet full text

Cover

More Information
Summary:After publication of our article [1] we were notified that the data presented in the upper row of Fig. 7 was inadvertently the least square mean change from baseline (standard error) at Month 6 rather than the overall average of Month 3 and Month 6. The figure legend and discussion of the data in the text were and are correct. The error was only in the upper row of Fig. 7. The legend for Fig. 7 did not require revision.
Bibliography:correction
ObjectType-Correction/Retraction-1
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Correction/Retraction-3
ISSN:1129-2369
1129-2377
1129-2377
DOI:10.1186/s10194-019-1069-x